CC BY
11
Whole-Genome Sequencing of Russian Neisseria Gonorrhoeae Isolates Related to ST 1407 Genogroup
A. A. Kubanov1, A. V. Runina1, A. V. Chestkov1, A. V. Kudryavtseva2, Y. A. Pekov3, I. O. Korvigo3, D. G. Deryabin1*
1State Research Centre of Dermatovenerology and Cosmetology, Korolenko Str., 3/6, Moscow, 107076, Russia
2Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilova Str., 32, Moscow, 119991, Russia
3Ksivalue Data Analysis Studio, Leninsky Ave., 30A, Moscow, 117628, Russia *E-mail: [email protected]
Received November 23, 2017; in final form June 27, 2018
Copyright © 2018 Park-media, Ltd. This is an open access article distributed under the Creative Commons Attribution License,which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
ABSTRACT The whole-genome sequencing data of three N. gonorrhoeae strains isolated in the Russian Federation in 2015 are presented. According to the NG-MAST protocol, these strains are related to the globally spread ST 1407 genogroup. The analysis of their resistomes showed the absence of ermA/B/C/F genes and the presence of wild-type alleles of rpsE, rrs, rrl, rplD, rplV, macAB, and mefA genes, and these patterns explain the susceptibility of the sequenced strains to aminocyclitols (spectinomycin) and macrolides (azithromycin). Conjugative resistance determinants (blaTEM, tetM) were absent in the genomes, and the penC/ pilQ, parE, and norM alleles were shown to be wild-type, whereas single or multiple nucleotide substitutions were identified in the genes encoding targets for P-lactams (ponA, penA), tetracyclines (rpsJ), and fluoroquinolones (gyrA, parC). The additional mutations were found in porB gene and the promoter of mtrR gene, which non-specifically reduced the susceptibility to antimicrobials due to the membrane permeability decrease and efflux pump overexpression. The diversity of mutations observed in the analyzed genomes prompted a revision of the phylogenetic relationships between the strains by comparing more than 790 groups of housekeeping genes. A high homology between the N. gonorrhoeae ST 1407 and N. gonorrhoeae ST 12556 genomes was confirmed; the latter had probably diverged from a common ancestor as a result of single mutation events. On the other hand, N. gonorrhoeae ST 12450 was an example of phenotypic convergence which appeared in the emergence of new drug resistance determinants that partially coincide with those of the ST 1407 genogroup. KEYWORDS Neisseria gonorrhoeae, whole genome sequencing, genetic determinants of antimicrobial drug resistance, phylogenetic analysis.
ABBREVIATIONS MIC - minimal inhibitory concentration, MLST - multilocus sequence typing, NG-MAST -Neisseria gonorrhoeae multi-antigen sequence typing, PBP - penicillin-binding protein, QRDR - quinolone resistance-determining regions, ST - sequence type.
INTRODUCTION
Gonorrhoea remains one of the four most widely spread sexually transmitted diseases. In 2012, its incidence among reproductive-age individuals reported by the WHO was 78.3 million new cases [1]. A total of 27,056 cases of gonococcal infection in 2015 in Russia, corresponding to 18.5 cases per 100,000, were reported [2]. Whereas in Russia these figures annually decrease by 10-20%, incidence of the infection worldwide continues to increase steadily.
The increase in gonorrhoea incidence is due to the appearance and spread of epidemic high-risk clones of Neisseria gonorrhoeae which possess multiple antibiotic resistance, including resistance to third-generation cephalosporins, the drugs of choice for treatment of the
infection [3]. Currently, the genetic variant referred to ST 1407 [5] in accordance with the NG-MAST (Neisseria gonorrhoeae Multi-Antigen Sequence Typing) protocol [4] has gained much significance. By 2010, this sequence type had been reported in 20 out of 21 states of the European Union, accounting for over 10% of isolates in 13 EU states (including Austria, Belgium, Italy, the Netherlands, Portugal, Romania, Slovenia, Spain, and the UK) [6]. Genetic analysis revealed multiple antibiotic resistance determinants in N. gonorrhoeae ST 1407 [7], and that explains the increasing ineffectiveness of gonococcal infection therapy [3, 5].
The epidemic significance of ST 1407 is additionally determined by the existence of phylogenetically related molecular types of N. gonorrhoeae that are 99%
amino acid identical to porB or tbpB genes used for NG-MAST typing and are, therefore, considered to belong to the ST 1407 genogroup. Considering this, the percentage of N. gonorrhoeae isolates in the EU states is as high as 23% [6], while one of the representatives of this genogroup, ST 4378, is the predominant sequence type in Taiwan [8].
Cases of gonococcal infection caused by N. gonorrhoeae ST 1407 are sporadic in Russia, being reported in cities with intensive touristic (Moscow) or economic (Kaluga and Murmansk) migration from the EU states [9]. Earlier, we reported few potential representatives of the genogroup ST 1407 detected in Russia for the first time [10]. This study aimed to perform an in-depth genome characterization of these isolates using whole-genome sequencing, which has recently become a high-demanded tool for analyzing the molecular mechanisms of antibiotic resistance and phylogeny of pathogenic microorganisms.
MATERIALS AND METHODS
N. gonorrhoeae strains
Three N. gonorrhoeae strains as objects of the study were isolated from patients with a diagnosis of gono-coccal infection of the lower genitourinary tract (ICD-10 diagnosis code A54.0) in 2015 and were deposited in a specialized collection of the State Research Center of Dermatovenereology and Cosmetology (Ministry of Health of the Russian Federation) with the identification codes 20/15/004, 41/15/003, and 19/15/005.
The N. gonorrhoeae strain 20/15/004 was isolated from a 41-year -old male patient in Kaluga; NG-MAST type referred to the epidemically high-risk genogroup ST 1407 (porB allele 908 and tbpB allele 110 according to the NG-MAST database nomenclature) [4]. N. gonor-rhoeae strain 41/15/003 was obtained from a 19-year-old male patient in Tomsk and characterized as a novel sequence type ST 12556 carrying a previously unknown combination of six tbpB alleles and porB allele 971; the latter exhibited 99.97% homology with ST 1407. N. gonorrhoeae strain 19/15/005 was isolated from a 31-year-old female patient in Omsk and was also characterized as being a novel ST 12450 NG-MAST type with the combination of porB allele 931 and the previously unknown tbpB allele 2097 and with a 99.74% homology and with six other alleles of this gene described earlier. An analysis of these strains within sample consisting of 124 N. gonorrhoeae cultures conducted by comparing the fusion sequences of the porB and tbpB genes using the MEGA 6 (Molecular Evolutionary Genetics Analysis version 6.0) software [11] demonstrated that they belong to one genogroup of ST 1407 [10].
Table 1. Parameters of susceptibility of the analyzed N. gonorrhoeae strains to antimicrobials and their interpretation according to the Methodology Guidelines MUK 4.2.1890-04*
Antimicrobial (zones of susceptibility - S, moderate susceptibility -MS, and resistance - R; ^g/ml) MIC, ^g/ml
20/15/004 41/15/003 19/15/005
Benzylpenicillin (S < 0.06; MS = 0.12-1; R > 2) 0.5 (MS) 2 (R) 1 (MS)
Ceftriaxone (S < 0.25; MS > 0.25) 0.015 (S) 0.03 (S) 0.015 (S)
Tetracycline (S < 0.25; MS = 0.5-1; R > 2) 2 (R) 4 (R) 2 (R)
Spectinomycin (S < 32; MS = 64; R > 128) 32 (S) 32 (S) 16 (S)
Azithromycin** (S < 0.25; MS = 0.5; R > 1) 0.25 (S) 0.5 (MS) 0.25 (S)
Ciprofloxacin (S < 0.06; MS = 0.12-0.5; R > 1) 16 (R) 8 (R) 16 (R)
'Methodology Guidelines MUK 4.2.1890-04. Determining Microorganism Susceptibility to Antibacterial Medications: Recommended Practices. Moscow: Federal Center of State Sanitary and Epidemiological Surveillance, Ministry of Health of the Russian Federation, 2004. P. 91. **As the Methodology Guidelines MUK 4.2.1890-04 contains no criteria for azithromycin susceptibility, the evaluation was carried out using the criteria of the European Committee for Antimicrobial Susceptibility Testing (www.eucast.org)
An analysis of the susceptibility of the studied strains to six antimicrobials previously or currently recommended for the treatment of gonococcal infection showed either resistance or moderate susceptibility of the strains to benzylpenicillin, tetracycline, and ciprofloxacin. N. gonorrhoeae 41/15/003 was additionally characterized by moderate susceptibility to azithromycin (Table 1).
Sequencing of the N. gonorrhoeae genome The genomic DNA was isolated from N. gonorrhoe-ae 1-colony cultures on chocolate agar supplemented with 1% ISOVitalex additive (Becton Dickinson, USA) incubated during 18-24 h using a PROBA-NK kit (DN-Technology, Russia). A library of random DNA fragments 400-700 bp long was prepared using the standard GS Rapid Library protocol. The libraries were amplified in emulsion PCR using GS Junior emPCR kit. Whole-genome sequencing was carried out by the 454
pyrosequencing technology on a GS Junior system (Roche, Switzerland). Each genome was sequenced using CS Junior Titanium Sequencing Kit in an individual sequencing run. The mean coverage of genomes was > 20.
Bioinformatic analysis methods
FastQC and Trimmomatic was used for the quality control and trimming. Remaining reads were assembled using Spades. Assembled N. gonorrhoeae genomes were annotated using Prokka [12], employing the Swiss-Prot (high-priority species-level references) and Un-iProt-KB (genus-level references) datasets of amino acid sequences. Prior to annotation, the UniProt-KB dataset was clustered using CD-HIT [13], with 90% identity of protein length and amino acid sequences. Ribosomal RNA genes were annotated using Barrnap (https://github.com/tseemann/barrnap). Aragorn was used to annotate tRNAs. IslandViewer 4 [14] was used to detect genomic islands.
The search for the genetic determinants of antibiotic resistance in N. gonorrhoeae was performed by RGI analysis in the Comprehensive Antibiotic Resistance Database (CARD) [15].
The NGMASTER software was employed for NG-MAST sequence typing of N. gonorrhoeae [16]; mul-tilocus MLST sequence typing was performed using the SRST2 software [17]. Orthologous protein groups belonging to the genus Neisseria were inferred by OrthoFinder [18] from annotated protein sequences of the
analyzed isolates and 24 previously sequenced N. gon-orrhoeae strains, as well as NCBI reference annotations of N. meningitidis, N. lactamica and N. elongata. Each of the 790 selected orthologous groups was subjected to multiple sequence alignment using MAFFT [19] with 2,000 refinement iterations. Each alignment was masked using Gblocks. Masked and concatenated alignments were used to infer a maximum likelihood phylogenetic tree of N. gonorrhoeae in RAxML [20] with 500 bootstrap replicates. The FigTree graphical viewer was used to visualize the tree with projected support values (http:// tree.bio.ed.ac.uk/software/figtree/).
In order to characterize the overall evolution of the coding sequences and the sequences associated with the formation of antimicrobial resistance, we formed two sets of concatenated multiple sequence alignments of the corresponding orthogroups and calculated the p-distance within each set. Matching between the cells of two resulting matrices was estimated using the Spearman's rank correlation coefficient.
RESULTS AND DISCUSSION
Overall characterization
of the N. gonorrhoeae genomes
The assembly of the genome sequences of the studied N. gonorrhoeae strains revealed a circular chromosome 2,223,815 to 2,271,213 bp long with G+C content of 52.5-52.7% in each genome (Table 2).
The total number of identified open reading frames was 2,448 (N. gonorrhoeae 20/15/004), 2,297 (N. gonorrhoeae 41/15/003), and 2,293 (N. gonorrhoeae 19/15/005). Among the genes, 1,332 (54.4%), 1,266 (55.1%), and 1,281 (55.9%) open reading frames were annotated as protein-coding genes with the known function, respectively.
Each of the analyzed genomes was found to contain 49 (N. gonorrhoeae 20/15/004 and N. gonorrhoeae 41/15/003) or 47 (N. gonorrhoeae 19/15/005) tRNA genes, one tmRNA gene, and four copies of 16S-23S-5S rRNA operon.
Cryptic plasmids varying in length from 4,556 (N. gonorrhoeae 20/15/004) to 5,266 bp (N. gonorrhoeae 19/15/005), carrying the relaxosome gene MobC (typical of conjugative plasmids), genes of the cryptic plas-mid proteins A, B, and C, and five open reading frames with unknown functions were identified for each strain. The rate of mean plasmid coverage to the mean chromosome coverage in 20/15/004 and 41/15/003 strains yielded 18.4 and 12.3, respectively, versus 33.6 in 19/15/005 strain, thus characterizing the revealed plasmids to be present in multiple copies (> 10 copies per cell).
In general, the first stage of bioinformatic analysis revealed the analyzed genomes to be similar to those of
Table 2. Overall characteristics of the genomes of the analyzed N. gonorrhoeae strains
Characteristics Strains
20/15/004 41/15/003 19/15/005
Genome size, bp 2271213 2236575 2223815
G+C content, % 52.6 52.5 52.7
Number of protein-coding genes 2448 2297 2293
Number of pro-
tein-coding genes with known function 1332 1266 1281
Number of the
16S-23S-5S rRNA 4 4 4
genes
Number of tRNA genes 49 49 47
Number of tmRNA 1 1 1
genes
Number of "genomic islands" along the bacterial chromosome 12 22 17
Plasmid size, bp 4556 5233 5266
Plasmid coverage depth to chromosome 18.4 12.3 33.6
coverage depth
Table 3. Genetic determinants of antimicrobial resistance in N. gonorrhoeae
Genes (proteins) Resistance to antimicrobials Genes and nucleotide polymorphisms (amino acid substitutions)
20/15/004 41/15/003 19/15/005
Enzymes responsible for inactivation of antibiotics or modification of their targets
blaTEM (ß-lactamase) ß-lactams - - -
ermA/B/C/F (rRNA methylases) macrolides - - -
Proteins targeting antibiotics
ponA (PBP,) P-lactams L421P L421P L421P
penA (PBP2) P-lactams I312M V316T F504L N512Y G545S I312M V316T F504L N512Y G545S F504L P551S
tetM tetracyclines - - -
rpsJ (S10) tetracyclines V57M V57M V57M
rpsE (S5) spectinomycin wt wt wt
rrs (16S RNA) spectinomycin wt wt wt
rrl (23S RNA) macrolides wt wt wt
rplD (L4) macrolides wt wt wt
rplV (L22) macrolides wt wt wt
gyrA fluoroquinolones S91F D95G S91F D95G S91F D95G
parC fluoroquinolones S87R E91A S87R E91A wt
parE fluoroquinolones wt wt wt
Transport proteins delivering antibiotics into the cell
penB /porB (PorB1b) ß-lactams tetracyclines G120K A121N G120K A121N G120D
penC / pilQ ß-lactams wt wt wt
Enzymatic antibiotic efflux systems
mtrCDE ß-lactams tetracyclines macrolides wt wt wt
mtrRpro A35del A35del wt
macAB macrolides wt wt wt
macABpro wt wt wt
mefA macrolides wt wt wt
norM fluoroquinolones wt wt wt
norMpro wt wt wt
Note: "-" - the gene was not found; "wt" - wild-type sequence.
the reference FA1090 (GenBank: AE004969) and some other previously sequenced N. gonorrhoeae strains [21], including those of the ST 1407 genogroup [22]. A degree of quantitative variations between the compared genomes could be caused by the high genome plasticity conventionally attributed to the presence of prophages, transposons, and the insertion sequence elements IS110 and IS1016 [23], which were revealed within genomic islands in all three N. gonorrhoeae strains in a substantially high amount (Table 2).
The sequences of the de novo assembled genomes were deposited into the GenBank NCBI database with IDs NTCT00000000 (N. gonorrhoeae 20/15/004),
NTCS00000000 (N. gonorrhoeae 41/15/003), and NTCU00000000 (N. gonorrhoeae 19/15/005).
Genetic determinants of antimicrobial resistance in N. gonorrhoeae
The next step in the bioinformatic analysis involved finding and studying four groups of genes encoding 1) the enzymes responsible for the inactivation of antibiotics or the modification of their targets, 2) the protein targets with mutations reducing their affinity for the respective antimicrobials, 3) the transport proteins delivering antibiotics into bacterial cell, and 4) the antibiotic efflux systems (Table 3).
Resistance determinants for P-lactams (penicillins and cephalosporins)
In the analyzed N. gonorrhoeae sequences, the results didn't reveal both blaTEM-1 or blaTEM-135 genes encoding the P-lactamase enzyme, which hydrolyzes the lactam ring in the penicillin molecule and other antimicrobials with a similar structure [24].
On the other hand, the sequences of chromosomal genes encoding penicillin binding proteins (PBPs) were found to carry a number of nucleotide substitutions that significantly reduce susceptibility to P-lactams. Thus, all three strains carried the mutation L421P in ponA gene encoding PBP: resulting in reduced affinity to penicillins compared to the wild-type protein [25]. Even greater changes were detected in the N. gonor-rhoeae 20/15/004 and N. gonorrhoeae 41/15/003 penA gene sequences (encoding PBP2), reflecting the concept of mosaic-like structure formed due to a genetic recombination with synanthropic commensals, such as N. cinerea and N. perflava [26]. More amino acid substitutions, namely F504L, N512Y, and G545S, were found in the C-terminal region of PBP2, and they significantly reduced the binding rate between the peptidyl trans-ferase center and the antimicrobial molecule imparing functionally important conformational changes [27]. Moreover, two other amino acid substitutions, I312M and V316T, are considered to be associated with the formation of cephalosporin resistance, especially in combination with the G545S substitution [28]. On behalf of this, two amino acid substitutions, F504L and P551S, which reduce the level of acylation of PBP2 as much as other known mutations in the C-terminal region of this protein characterizing the penA allele in N. gonorrhoeae 19/15/005 [29].
The penB gene encoding the outer membrane porin PorB1b and currently denoted as porB, is also involved in the emergence of resistance to P-lactams in N. gonorrhoeae. The amino acid substitutions G120K and A121N in this protein reducing membrane permeability for hydrophilic antibiotics [30] were detected in N. gonorrhoeae 20/15/004 and N. gonorrhoeae 41/15/003, whereas the N. gonorrhoeae 19/15/005 strain carried a single G120D substitution.
The pilQ gene (previously known as penC) is another studied gene attributed to the resistance to P-lactams and other hydrophilic antibiotics in N. gonorrhoeae. The additional pores formed in the outer membrane by the product of this gene enable antibiotic diffusion into the periplasmic space of the bacterial cell. Mutation in the triplet 666(Gly) or complete deletion of pilQ gene can increase the level of antibiotic resistance in N. gonor-rhoeae, especially when accompanied with the resistance determinants in the penA and penB genes [31]. However, this gene was wild-type in the analyzed genomes.
To finalize the analysis of the resistance determinants to P-lactams in N. gonorrhoeae, we must point out the three tangled genes present in all the analyzed strains. These genes lie within the multiple transferable resistance (Mtr) locus controlled by the MtrR repressor and encode the MtrC-MtrD-MtrE efflux pump system. The analysis of the mtrR promoter region revealed deletion A35del, which ensured elimination of this repression, together with an increase in antibiotic resistance [32]. This mutation was found in the N. gonorrhoeae strain 20/15/004 (ST 1407) and in the structurally related N. gonorrhoeae strain 41/15/003 (ST 12556) with a similar structure of porB gene. This is in accordance with the hypothesis that gonococci of the 1407 NG-MAST genogroup possess the above discussed mechanism of antibiotic resistance [5].
Tetracycline resistance determinants
A point mutation causing the amino acid substitution V57M in ribosomal protein S10 of the 30S ribosomal subunit was found in the chromosomal rpsJ gene in all three analyzed genomes. This substitution disrupts binding of the antimicrobial to ribosome and allows one to concider this as the mechanism underlying the resistance to tetracyclines in N. gonorrhoeae [33].
On the other hand, the genomes of the three analyzed strains were found to carry no Dutch or American variants of tetM gene [34]; the protein products of the variants interfere with the elongation factors EF-G and EF-Tu and make the ribosome inaccessible for interaction with the antimicrobial.
In turn, the nonspecific mechanisms of resistance to tetracyclines (identically to P-lactams) in the analyzed strains involved mutations in PorB1b protein and MtrC-MtrD-MtrE efflux system, which is an effective supplement to the specific resistance mechanism caused by a mutation in rpsJ gene [33].
Spectinomycin resistance determinants
The nucleotide sequence in rrs gene matched the sequence of a wild-type gene with cytosine at position 1186 (corresponding to position 1192 in Escherichia coli); this is the key nucleotide in the binding site for the interaction of aminocyclitols with helix 34 of 16S RNA [35].
Another analyzed chromosomal determinant was rpsE gene, which encodes the ribosomal protein S5 of 30S ribosomal subunit; mutations in this protein can cause spectinomycin resistance, although rrs gene remains to be wild-type. However, searching for the possible amino acid substitutions T24P [36] and K28E, as well as for deletion of codon 27 (Val) [37], confirmed the wild-type allele of rpsE gene.
Macrolide resistance determinants
Neither of the analyzed genomes contained ermA/B/C/F gene cluster, which codes rRNA meth-ylases modifying the macrolide binding sites of the 23S rRNA molecule.
The results of the search for A2059G and C2611T mutations in rrl gene, which disrupt the interaction between macrolide antibiotics and their target (the pep-tidyl transferase center) in domain V of 23rRNA [38], indicate that all three strains were wild-type.
The products of the rplD and rplV genes (ribosomal proteins L4 and L22) that bind to domain I of 23S rRNA and likewise have multiple binding sites for the other domains of 23S rRNA, were also wild-type. Mutations in the L4 and L22 proteins alter the conformation of domains II, III, and V; this may affect the susceptibility of microorganisms to macrolides [39].
The analysis of N. gonorrhoeae resistance to macro-lides revealed that all the three genomes possess functional alleles of the macA and macB genes encoding the MacA-MacB complex, which specifically recognizes and removes the antimicrobial from the periplasm of bacterial cells [40]. However, an analysis of position -10 of promoters of these genes characterized them as wild-type without efflux pump overexpression. The mefA gene encoding another transport protein responsible for macrolide resistance [41] was also wild-type in the studied genomes.
Fluoroquinolone resistance determinants
The search for chromosomal mutations defining fluo-roquinolone resistance in N. gonorrhoeae included the analysis of quinolone resistance-determining regions (QRDRs) in the gyrA, parC, and parE genes encoding DNA gyrase subunit A, as well as the topoisomerase IV subunits C and E, the fluoroquinolone targets.
In the all three strains, gyrA gene was found to contain single-nucleotide polymorphisms TCC ^ TTC and GAC ^ GGC causing the S91F and D95G amino acid substitutions associated with fluoroquinolone resistance in N. gonorrhoeae [42].
The parC gene in N. gonorrhoeae 20/15/004 and N. gonorrhoeae 41/15/003 possessed wild-type triplets (86(D) and 88(S)), indicating a double mutation with S87R and E91A amino acid substitutions. This mutation, together with the changes in DNA gyrase, significantly modified the structure of the so-called quinolone-binding pocket [43], making impossible the interaction between the antimicrobial and the target. The analysis of all four amino acid substitutions demonstrated the presence of the wild-type parC gene in the genome of N. gonorrhoeae 19/15/005. Wild-type parE gene was present in all the analyzed N. gonorrhoeae trains.
Characterization of the nonspecific mechanism of fluoroquinolone resistance in N. gonorrhoeae revealed that each of the studied genomes contained one functional copy of the norM gene encoding the membrane transporter that removes cationic antimicrobials from the bacterial cell [44]. Also, the promoter region at position -35 was wild-type, suggesting no additional efflux pump overexpression.
Molecular typing and phylogenetic analysis of N. gonorrhoeae
The variation of antibiotic resistance determinants in the studied genomes of N. gonorrhoeae strains required a revision of their phylogenetic relationship. In this regard, we used a combination of NG-MAST and multilocus sequence typing (MLST) results to plot a dendrogram comparing the entire set of housekeeping genes.
The findings of the sequenced genomes analysis using the NGMASTER software [16] revealed a complete coincidence with the initial data referring the analyzed strains to the genogroups ST 1407, ST 12556, and ST 12450 (Table 4).
Furthermore, the SRST2 analysis [17] of the nucle-otide sequences of conserved abcZ, adk, aroE, fumC, gdh, pdhC, and pgm genes [45] revealed N. gonorrhoeae strains 20/15/004 and 41/15/003 to refer to the MLST type 1901, which relates to the epidemic high-risk ST 1407 according to the NG-MAST sequence typing data [5]. On the other hand, four of seven alleles of N. gonorrhoeae 19/15/005 characterized this strain as the MLST type 6721. This has never been mentioned in publications concerning antimicrobial resistance, and the phylogenetic relation with ST 1407 has never been described.
Table 4. Results of molecular mapping of N. gonorrhoeae
Genes and the encoded molecular types (NG-MAST and MLST) Sequence types and numbers of alleles of N. gonorrhoeae strains
20/15/004 41/15/003 19/15/005
NG-MAST 1407 12556 12450
porB 908 971 931
tbpB 110 6 2097
MLST 1901 1901 6721
abcZ 109 109 126
adk 39 39 39
aroE 170 170 67
fumC 111 111 111
gdh 148 148 146
pdhC 153 153 153
pgm 65 65 133
The phylogenetic relationship between the strains were evaluated by comparing the entire set of 790 or-thologous groups of housekeeping genes in Neisseria-ceae family members. We used additional data from the NCBI database on the genomes of the N. meningitidis and 24 N. gonorrhoeae strains, including the reference strain FA 19, five previously sequenced ST 1407 strains, and 18 strains of other NG-MAST types. Figure shows the phylogenetic tree designed by maximum likelihood estimation using the RAxML program [20] (the Gamma substitution model in combination with the BLOSUM62 scoring matrix). In order to assess the relation between the evolution of neutral coding sequences and the sequences involved in the formation of antibiotic resistance, we compared this phylogenetic tree to the dendrogram plotted for the orthologous groups associated with antimicrobial resistance.
The resulting data show an extremely high genotype likelihood between the strains 20/15/004 (ST 1407) and 41/15/003 (ST 12556), according to the set of housekeeping genes combined to a single cluster with the other previously sequenced representatives of the genogroups ST 1407, ST 6146, and ST 3520. Hence, the results of the study confirmed the hypothesis of a close phylogenetic relation between the analyzed strains. The first strain emerged in the population of N. gon-orrhoeae in Russia after putative international migration, while the other one has diverged from their common ancestor as a result of single mutation events. On the other hand, the third analyzed strain, 19/15/005 (ST 12450), was substantially distant from the ST 1407 genogroup on the phylogenetic tree of housekeeping genes and exhibited no close genotypic relation to any of the formed genogroups. Therefore, there was a prominent discordance between the primary molecular typing data and the results of whole-genome sequencing of this strain, indicating that antibiotic-resistant strains in the current Russian N. gonorrhoeae population are polyphyletic.
Comparison of the concatenated multiple alignments of neutral coding sequences and sequences associated with the formation of antimicrobial resistance revealed a statistically significant (p < 0.001) positive correlation (the Pearson's correlation coefficient = 0.44). In particular, this correlation was demonstrated for representatives of genogroup ST 1407 (including 20/15/004 and 41/15/003 strains), except for ST 3520. The latter sequence type was also an isolate characterized by a mosaic structure of penA gene [46] but with probably its own independently developed mechanisms of antimicrobial resistance. The analysis of N. gonorrhoeae 19/15/005 (ST 12450) has confirmed the relatively independent phylogenetic position of this strain.
CONCLUSIONS
Whole-genome sequencing of three N. gonorrhoeae strains isolated in Russia in 2015 was performed [10]. According to the NG-MAST results, these strains possess multiple antimicrobial resistance and preliminarily were referred to the epidemic high-risk genogroup ST 1407, spread currently worldwide [6, 8].
The analysis of the genomes revealed that they essentially pertain to the reference N. gonorrhoeae strain FA1090 [21] and previously sequenced representatives of the ST 1407 genogroup [22]. The revealed absence of ermA/B/C/F genes and presence of wild-type alleles of the rpsE, rrs, rrl, rplD, rplV, macAB, and mefA genes explain the susceptibility of the studied strains to certain groups of antimicrobials, as mutations in these genes are associated with the emergence of resistance to aminocyclitols (spectinomycin) and macrolides (azithromycin). However, the conjugative resistance determinants (blaTEM, tetM) were absent in the genomes and the penC/pilQ, parE, and norM alleles were shown to be wild-type, whereas single or multiple nucleotide substitutions were identified in the genes encoding targets for P-lactams (ponA, penA), tetracyclines (rpsJ), and fluoroquinolones (gyrA, parC). The additional mutations were found in porB gene and the promoter of mtrR gene and, therefore, they nonspe-cifically reduced the susceptibility to antimicrobials due to membrane permeability decreasing and efflux pump overexpression. Hence, the findings in the results of the whole-genome sequencing coincide with the preliminary results of the phenotypic analysis. The analysis of genetic resistance determinants allowed us to predict susceptibility or resistance to certain antimicrobial groups, but no MIC values could be inferred from these data. In particular, although the genotypes of the N. gonorrhoeae strains 20/15/004 (ST 1407) and 41/15/003 (ST12556) are similar, the increased resistance of the latter from 2 up to 4-fold to penicillin, cef-triaxone, tetracycline, and azithromycin remains unexplained. Otherwise, the different mutation spectra of the genes involved in emergence of antimicrobial resistance in N. gonorrhoeae 20/15/004 (ST 1407) and 19/15/005 (ST 12450) resulted in similar parameters of antimicrobial resistance. This indicates the importance of the search for additional mechanisms of antimicrobial resistance in N. gonorrhoeae and developing computer algorithms to ensure sufficient consistency between the results of genotypic and phenotypic analyses [47].
Another important result of this study was the revision of the phylogenetic association of the analyzed clinical isolates, compared to initially formulated findings acording to the NG-MAST data. This study has confirmed a high homology between the N. gonorrhoeae 20/15/004 (ST 1407) and N. gonorrhoeae 41/15/003
0.00 0.01 0.020 0.022 0.024 0.00 0.02 0.04 0.06
Phylogenic mapping of the analyzed isolates (NG1 = 20/15/004; NG2 = 41/15/003; NG3 = 19/15/005) referring to the other N. gonorrhoeae strains studied previously. Phylogenic mapping was performed by comparing the housekeeping genes (left-hand side) and orthologous groups related to the emergence of antimicrobial resistance (right-hand side). The correspondence of genome numbering in the NCBI database: ST 1407-I = SRR3349203; ST 1407-II = SRR3349826; ST 1407-III = SRR3357181; ST 1407-IV = SRR3357194; ST 1407-V = PMC3486552; ST 5 = SRR3349550; ST 217 = SRR3349568; ST 384 = SRR3350138; ST 1650 = SRR3343502; ST 3520 = SRR3357021; ST 3916 = SRR3343568; ST 4244 = SRR3350168; ST 4669 = SRR1661263; ST 4758 = SRR3343553; ST 4943 = SRR3349831; ST 4995 = SRR3349564; ST 6146 = SRR3349969; ST 8030 = SRR3349209; ST 9368 = SRR2736298; ST 9918 = SRR3349572; ST 10149 = SRR3349522; ST 10419 = SRR3343607; ST 10806 = SRR3349206; ST 11371 = SRR3349525.
The length of the branches of the phylogenetic tree (X axis) corresponds to the number of expected amino acid substitutions per position. The values at branch nodes represent the level of branch support. Red lines connect the homony-mous branches
(ST 12556) genomes; the latter probably diverged in Russia from a representative of the internationally spread ST 1407 clone. On the other hand, N. gonorrhoeae strain 19/15/005 (ST 12450) was an example of phenotypic and genotypic convergence with independent formation of antimicrobial resistance by its own,
although partially similar, mechanisms. This result indicates the antibiotic resistant strains in the population of N. gonorrhoeae in Russia as being polyphyletic, and this give reasons for further research in order to identify and consider an expanded list of epidemic high-risk genotypes.
REFERENCES 1. Newman L., Rowley J., Vander Hoorn S., Wijesooriya N.S., Unemo M., Low N., Stevens G., Gottlieb S., Kiarie J., Tem-merman M. // PLoS One. 2015. V. 10. e0143304.
2. Kubanova А.А., Kubanov А.А., Melekhina L.E., Bogdanova E.V. // Vestnik dermatologii i venerologii. 2016. № 3. P. 12-28.
3. Ohnishi M., Golparian D., Shimuta K., Saika T., Hoshina S., Iwasaku K., Nakayama S., Kitawaki J., Unemo M. // Anti-
microb. Agents Chemother. 2011. V. 55. № 7. P. 3538-3545.
4. European centre for disease prevention and control. Molecular typing of Neisseria gonorrhoeae - results from a pilot study 2010-2011. 2012. Stockholm. ECDC.
5. Unemo M., Golparian D., Stary A., Eigentler A. // Euro Surveill. 2011. V. 16. № 43. Pii. 19998.
6. Chisholm S.A., Unemo M., Quaye N., Johansson E., Cole M.J., Ison C.A., van de Laar M.J. // Euro Surveill. 2013. V. 18. № 3. Pii. 20358.
7. Unemo M. // BMC Infect. Dis. 2015. V. 15. P. 364.
8. Chen C.C., Yen M.Y., Wong W.W., Li L.H., Huang Y.L., Chen K.W., Li S.Y. // J. Antimicrob. Chemother. 2013. V. 68. № 7. P. 1567-1571.
9. Vorobyev D.V., Solomka V.S., Plakhova X.I., Deryabin D.G., Kubanov A.A // Journal of Microbiology, Epidemiology and Immunobiology. 2016. № 4. P. 42-50.
10. Kubanov A., Vorobyev D., Chestkov A., Leinsoo A., Shaskolskiy B., Dementieva E., Solomka V., Plakhova X., Gryadunov D., Deryabin D. // BMC Infect. Dis. 2016. V. 16. P. 389.
11. Tamura K., Stecher G., Peterson D., Filipski A., Kumar S. // Mol. Biol. Evol. 2013. V. 30. № 12. P. 2725-2729.
12. Seemann T. // Bioinformatics. 2014. V. 30. № 14. P. 20682069.
13. Fu L., Niu B., Zhu Z., Wu S., Li W. // Bioinformatics. 2012. V. 28. № 23. P. 3150-3152.
14. Bertelli C., Laird M.R., Williams K.P., Lau B.Y., Hoad G., Winsor G.L., Brinkman F.S. // Nucl. Acids Res. 2017. V. 45. W30-W35.
15. McArthur A.G., Waglechner N., Nizam F., Yan A., Azad M.A., Baylay A.J., Bhullar K., Canova M.J., De Pascale G., Ejim L., et al. // Antimicrob. Agents Chemother. 2013. V. 57. № 7. P. 3348-3357.
16. Kwong J.C., Gongalves da Silva A., Dyet K., Williamson D.A., Stinear T.P., Howden B.P., Seemann T. // Microb. Genom. 2016. V. 2. № 8. e000076.
17. Inouye M., Dashnow H., Raven L.A., Schultz M.B., Pope B.J., Tomita T., Zobel J., Holt K.E. // Genome Med. 2014. V. 6. № 11. P. 90.
18. Emms D.M., Kelly S. // Genome Biol. 2015. V. 16. № 1. P. 157.
19. Katoh K., Standley D.M. // Mol. Biol. Evol. 2013. V. 30. № 4. P. 772-780.
20. Stamatakis A. // Bioinformatics. 2014. V. 30. № 9. P. 1312-1313.
21. Abrams A.J., Trees D.L., Nicholas R.A. // Genome An-nounc. 2015. V. 3. № 5. e01052-15.
22. Anselmo A., Ciammaruconi A., Carannante A., Neri A., Fazio C., Fortunato A., Palozzi A.M., Vacca P., Fillo S., Lista F., et al. // Genome Announc. 2015. V. 3. № 4. e00903-15.
23. Bodoev I.N., Ilina E.N. // Molecular Genetics, Microbiology and Virology. 2015. V. 33. № 3. P. 22-27.
24. Muhammad I., Golparian D., Dillon J.A., Johansson A., Ohnishi M., Sethi S., Chen S.C., Nakayama S., Sundqvist M., Bala M., et al. // BMC Infect. Dis. 2014. V. 14. P. 454.
25. Ropp P.A., Hu M., Olesky M., Nicholas R.A. // Antimicrob. Agents Chemother. 2002. V. 46. № 3. P. 769-777.
26. Ameyama S., Onodera S., Takahata M., Minami S., Maki N., Endo K., Goto H., Suzuki H., Oishi Y. // Antimicrob. Agents Chemother. 2002. V. 46. № 12. P. 3744-3749.
27. Takahata S., Senju N., Osaki Y., Yoshida T., Ida T. // Antimicrob. Agents Chemother. 2006. V. 50. № 11. P. 3638-3645.
28. Tomberg J., Unemo M., Davies C., Nicholas R.A. // Biochemistry. 2010. V. 49. № 37. P. 8062-8070.
29. Powell A.J., Tomberg J., Deacon A.M., Nicholas R.A., Da-vies C. // J. Biol. Chem. 2009. V. 284. № 2. P. 1202-1212.
30. Olesky M., Zhao S., Rosenberg R.L., Nicholas R.A. // J. Bacteriol. 2006. V. 188. № 7. P. 2300-2308.
31. Helm R.A., Barnhart M.M., Seifert H.S. // J. Bacteriol. 2007. V. 189. № 8. P. 3198-3207.
32. Veal W.L., Nicholas R.A., Shafer W.M. // J. Bacteriol. 2002. V. 184. № 20. P. 5619-5624.
33. Hu M., Nandi S., Davies C., Nicholas R.A. // Antimicrob. Agents Chemother. 2005. V. 49. № 10. P. 4327-4334.
34. Turner A., Gough K.R., Leeming J.P. // Sex Transm. Infect. 1999. V. 75. № 1. P. 60-66.
35. Galimand M., Gerbaud G., Courvalin P. // Antimicrob. Agents Chemother. 2000. V. 44. № 5. P. 1365-1366.
36. Ilina E.N., Malakhova M.V., Bodoev I.N., Oparina N.Y., Filimonova A.V., Govorun V.M. // Front. Microbiol. 2013. V. 4. P. 186.
37. Unemo M., Golparian D., Skogen V., Olsen A.O., Moi H., Syversen G., Hjelmevoll S.O. // Antimicrob. Agents Che-mother. 2013. V. 57. № 2. P. 1057-1061.
38. Jacobsson S., Golparian D., Cole M., Spiteri G., Martin I., Bergheim T., Borrego M.J., Crowley B., Crucitti T., van Dam A.P., et al. // J. Antimicrob. Chemother. 2016. V. 71. № 11. P. 3109-3116.
39. Gregory S.T., Dahlberg A.E. // J. Mol. Biol. 1999. V. 289. № 4. P. 827-834.
40. Rouquette-Loughlin C.E., Balthazar J.T., Shafer W.M. // J. Antimicrob. Chemother. 2005. V. 56. № 5. P. 856-860.
41. Cousin S.J., Whittington W.L., Roberts M.C. // Antimicrob. Agents Chemother. 2003. V. 47. № 12. P. 3877-3880.
42. Shultz T.R., Tapsall J.W., White P.A. // Antimicrob. Agents Chemother. 2001. V. 45. № 3. P. 734-738.
43. Su X., Lind I. // Antimicrob Agents Chemother. 2001. V. 45. № 1. P. 117-123.
44. Rouquette-Loughlin C., Dunham S.A., Kuhn M., Balthazar J.T., Shafer W.M. // J. Bacteriol. 2003. V. 185. № 3. P. 1101-1106.
45. Jolley K.A., Maiden M.C. // Future Microbiol. 2014. V. 9. № 5. P. 623-630.
46. Ison C.A., Town K., Obi C., Chisholm S., Hughes G., Liver-more D.M., Lowndes C.M.; GRASP collaborative group. // Lancet Infect. Dis. 2013. V. 13. № 9. P. 762-768.
47. Eyre D.W., De Silva D., Cole K., Peters J., Cole M.J., Grad Y.H., Demczuk W., Martin I., Mulvey M.R., Crook D.W., et al. // J. Antimicrob. Chemother. 2017. V. 72. № 7. P. 1937-1947.
